Regeneron is the second pharma group to sign up for access to data from a remote study run by health technology firm Koneksa that is exploring the use of digital biomarkers to track patients with ...

Regeneron has signed a collaboration deal potentially worth $1 billion with RNAi experts Alnylam Pharmaceuticals, to develop and commercialise drugs targeting eye, central nervous system (CNS ...

Emily Davies covers the federal government's impact in the D.C. area. Send her secure tips on Signal at emilydavies.46 Education: Brown University, B.A. Emily Davies is a reporter covering the ...

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the resubmission of the Biologics License Application (BLA ...

Emily Wahls is the Chief Meteorologist at FOX 32 Chicago. She joined the WFLD team in September 2021. Before coming to Chicago, Emily worked as the chief meteorologist for WILX in Lansing, Michigan.